Marker Therapeutics Inc (MRKR)
4.11
+0.06
(+1.48%)
USD |
NASDAQ |
May 01, 16:00
4.10
-0.01
(-0.24%)
After-Hours: 20:00
Marker Therapeutics Price to Book Value: 2.604 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 2.604 |
| April 30, 2024 | 2.566 |
| April 29, 2024 | 2.607 |
| April 26, 2024 | 2.718 |
| April 25, 2024 | 2.765 |
| April 24, 2024 | 2.788 |
| April 23, 2024 | 2.803 |
| April 22, 2024 | 2.654 |
| April 19, 2024 | 2.623 |
| April 18, 2024 | 2.598 |
| April 17, 2024 | 2.731 |
| April 16, 2024 | 2.788 |
| April 15, 2024 | 2.813 |
| April 12, 2024 | 2.731 |
| April 11, 2024 | 2.914 |
| April 10, 2024 | 3.073 |
| April 09, 2024 | 2.978 |
| April 08, 2024 | 2.984 |
| April 05, 2024 | 2.959 |
| April 04, 2024 | 3.092 |
| April 03, 2024 | 2.883 |
| April 02, 2024 | 2.762 |
| April 01, 2024 | 2.914 |
| March 28, 2024 | 2.724 |
| March 27, 2024 | 2.746 |
| Date | Value |
|---|---|
| March 26, 2024 | 2.737 |
| March 25, 2024 | 3.066 |
| March 22, 2024 | 3.111 |
| March 21, 2024 | 2.940 |
| March 20, 2024 | 2.851 |
| March 19, 2024 | 2.788 |
| March 18, 2024 | 2.737 |
| March 15, 2024 | 2.806 |
| March 14, 2024 | 2.831 |
| March 13, 2024 | 2.742 |
| March 12, 2024 | 2.673 |
| March 11, 2024 | 2.622 |
| March 08, 2024 | 2.597 |
| March 07, 2024 | 2.508 |
| March 06, 2024 | 2.495 |
| March 05, 2024 | 2.514 |
| March 04, 2024 | 2.419 |
| March 01, 2024 | 2.337 |
| February 29, 2024 | 2.299 |
| February 28, 2024 | 2.312 |
| February 27, 2024 | 2.343 |
| February 26, 2024 | 2.394 |
| February 23, 2024 | 2.495 |
| February 22, 2024 | 2.502 |
| February 21, 2024 | 2.483 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3494
Minimum
Mar 30 2023
8.682
Maximum
Mar 22 2021
2.453
Average
2.430
Median
Sep 13 2021
Price to Book Value Benchmarks
| AIM ImmunoTech Inc | 2.039 |
| Perspective Therapeutics Inc | 13.27 |
| Protalix BioTherapeutics Inc | 2.633 |
| Electromed Inc | 3.765 |
| Armata Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
| Price | 4.11 |
| Earnings Yield | -22.87% |
| Market Cap | 36.59M |